Buy This Stock For +22% Return, In 12 Months

The brokerage firm CD Equisearch has recommended investors to buy stocks of Acrysil with a potential upside of 22.4%, within a target period of 1 year.

Target Price

The Current Market Price (CMP) of Macrotech Developers is Rs. 812. The brokerage firm, CD Equisearch has estimated a Target Price for the stock at Rs. 994. Hence the stock is expected to give a 22.4% return, in a Target Period of 1 year.

Stock Outlook
Current Market Price (CMP)	Rs. 812
Target Price	Rs. 994
1 year returns	22.40%

Company performance

The company's income from operation stood at Rs. 309.72 crore, in FY 2021, and CD Equisearch is expecting Rs. 474.85 crore sales in FY22 and Rs. 627.44 crore sales in FY23 for the same. On the other hand, Consolidated Net Profit (Adjusted) was Rs. 39.11 crore in FY 21; the firm is anticipating Rs. 65.62 crore in FY 22, and a Rs. 85.65 crore in FY 23, for the same.

Comments by CD Equisearch

Maintaining a buy rating, the brokerage firm said, "The stock currently trades at 33.0x FY22e EPS of Rs. 24.58 and 25.3x FY23e EPS of Rs. 32.08. Keeping in mind that this sudden spurt in growth could be due to the pent-up demand and the trend might not be long-term, the management is increasing the capacities in a phased manner, thereby maintaining its market share."

About the company

Acrysil is one of the largest producers of quartz kitchen sinks in the world using Schock technology. Other major business verticals are kitchen appliances and bathroom suites. The Sinks are sold to discerning customers in over 30 countries worldwide like the USA, UK, Germany, France, Canada, China, Far East, and Gulf Countries. Acrysil has also set up a wholly-owned subsidiary, Acrysil GmbH in Germany to further strengthen its presence in the demanding European markets.

Disclaimer

The above stock was picked from the brokerage report of CD Equisearch. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.

(Also read: Buy This Stock For +17% Return, In 1 Year)